RKL Wealth Management’s GSK GSK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $272K | Hold |
7,083
| – | – | 0.02% | 160 |
|
2025
Q1 | $274K | Sell |
7,083
-941
| -12% | -$36.5K | 0.03% | 158 |
|
2024
Q4 | $271K | Buy |
8,024
+919
| +13% | +$31.1K | 0.02% | 151 |
|
2024
Q3 | $290K | Sell |
7,105
-2
| -0% | -$82 | 0.03% | 129 |
|
2024
Q2 | $274K | Sell |
7,107
-13
| -0.2% | -$501 | 0.03% | 123 |
|
2024
Q1 | $305K | Buy |
7,120
+13
| +0.2% | +$557 | 0.03% | 121 |
|
2023
Q4 | $263K | Buy |
+7,107
| New | +$263K | 0.03% | 130 |
|
2017
Q4 | – | Sell |
-8,434
| Closed | -$425K | – | 141 |
|
2017
Q3 | $425K | Sell |
8,434
-3,108
| -27% | -$157K | 0.12% | 109 |
|
2017
Q2 | $621K | Sell |
11,542
-2,932
| -20% | -$158K | 0.2% | 97 |
|
2017
Q1 | $762K | Sell |
14,474
-3,876
| -21% | -$204K | 0.31% | 60 |
|
2016
Q4 | $883K | Sell |
18,350
-2,010
| -10% | -$96.7K | 0.43% | 52 |
|
2016
Q3 | $1.1M | Buy |
20,360
+3,506
| +21% | +$189K | 0.55% | 44 |
|
2016
Q2 | $897K | Buy |
16,854
+6,562
| +64% | +$349K | 0.47% | 46 |
|
2016
Q1 | $522K | Buy |
+10,292
| New | +$522K | 0.3% | 46 |
|